3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Active not recruiting
6
Terminated
2
Recruiting
2
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Lymphoid
2
Conditions
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Neoplasms
1
Interventions
Specimen Handling
311
Magnetic Resonance Spectroscopy
266
pembrolizumab
251
Carboplatin
184
Cyclophosphamide
176
Biopsy
172
Cisplatin
157
Gemcitabine
134
Paclitaxel
131
Bevacizumab
124
fludarabine
117
Radiotherapy
108
Nivolumab
108
Oxaliplatin
88
Docetaxel
87
Fluorouracil
85
Capecitabine
83
venetoclax
82
Dexamethasone
77
Pemetrexed
72
Rituximab
71
Leucovorin
69
Drug Therapy
69
atezolizumab
67
durvalumab
66
Radiosurgery
65
Blood Specimen Collection
65
Standard of Care
63
Doxorubicin
63
Radiation
61
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
temsirolimus
×
90 days
×
Clear all
NCT02693535
2026-05-29
TAPUR
American Society of Clinical Oncology
Phase 2
Recruiting
4,200 enrolled
NCT03297606
2026-03-27
CAPTUR
Canadian Cancer Trials Group
Phase 2
Recruiting
720 enrolled